Intestinal Microbiota Capsule Composition for Viability and Storage Stability

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for preparing intestinal microbiota pellets, such as freeze-drying, result in reduced microbial viability, structural changes, and limited ambient-temperature stability, posing challenges for clinical deployment and patient safety.

Innovation Solution

A composition and method involving an eluent with plant extracts and Magnolia officinalis powder, combined with a protective agent and separation aid, to preserve microbial viability and enhance storage stability, using a device with specific filtration and centrifugation steps.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If freeze-drying treatment is used to prepare intestinal microbiota products, then the preparation process is simplified, but microbial viability is significantly reduced and microbial structure changes occur

Engineering Contradiction:
Improvepreparation process simplicityVSAvoidmicrobial viability
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The patent changes the preparation parameters from freeze-drying to a novel extraction method using specific eluents (buffer solution with pH 7.0-7.5) and controlled temperature (4°C-37°C), which preserves microbial viability while maintaining processability

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent introduces a protective agent system comprising multiple components (protective polysaccharide, protective protein, protective enzyme) that act as intermediaries to protect microorganisms during the extraction and preparation process, preventing damage while enabling simplified processing

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If microbiota pellet is prepared by separating undigested food residues and metabolites, then microbial viability is preserved, but the preparation process becomes more complex and ambient-temperature stability is limited

Engineering Contradiction:
Improvemicrobial viabilityVSAvoidpreparation process complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent extracts and removes harmful components (undigested food residues, metabolites, and other contaminants) through a systematic filtration and centrifugation process, isolating the microbial community while simplifying the overall preparation workflow

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent creates a composite protective system combining multiple protective agents (polysaccharide, protein, enzyme) that work synergistically to maintain microbial viability and enhance stability, reducing the need for complex separate processing steps

Inventive Principle:
Principle #40Composite materials

3Stability of the object's composition

If cryogenic storage at -80°C is used, then storage stability is improved, but ice crystals form and pierce bacterial cell walls causing cell death

Engineering Contradiction:
Improvestorage stabilityVSAvoidmicrobial viability
Core Design Contradiction:
Stability of the object's compositionVSReliability

Solution Approach 1:

The patent applies protective agents (particularly protective polysaccharide and protective protein) beforehand to form a protective barrier around bacterial cells before cryogenic storage, cushioning them against ice crystal damage and maintaining viability during storage

Inventive Principle:
Principle #11Beforehand cushioning (Prior cushioning)

Solution Approach 2:

The patent modifies the storage parameters by adding protective agents that change the freezing behavior of the microbial community, preventing ice crystal formation or reducing their harmful effects while maintaining low-temperature storage stability

Inventive Principle:
Principle #35Parameter changes

4Ease of manufacture

If improper extraction methods are used, then preparation is simplified, but adverse effects occur on microbial viability and viable bacterial load increase

Engineering Contradiction:
Improveextraction process simplicityVSAvoidmicrobial viability and viable bacterial load
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The patent optimizes extraction parameters including eluent composition (buffer solution with specific pH 7.0-7.5), temperature (4°C-37°C), and processing time to achieve simple yet effective extraction that preserves microbial viability and increases viable bacterial load

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent introduces protective agents as intermediaries during the extraction process that facilitate the separation of microbial community from contaminants while protecting microorganisms from damage, enabling simplified extraction without compromising viability

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method achieves low-odor, high-viability intestinal microbiota pellets with improved storage stability, maintaining taxonomic abundance and viability for precise transplantation.

Implementation Method 1

using a device with specific filtration and centrifugation steps

Methodology Applied
Scientific EffectFiltration: Filter (physical)

Implementation Method 2

using a device with specific filtration and centrifugation steps

Methodology Applied
Scientific EffectCentrifugation: Centrifuge

Implementation Method 3

combined with a protective agent and separation aid, to preserve microbial viability and enhance storage stability

Methodology Applied
Scientific EffectProtective effect:

Implementation Method 4

A composition and method involving an eluent with plant extracts and Magnolia officinalis powder

Methodology Applied
Scientific EffectAdsorption: Adsorption

Data Source

PatentUS20260014212A1Intestinal microbiota product, capsule, preparation method and device thereof, and use thereof in precise intestinal microbiota transplantation
Publication Date: 2026.01.15 XIAMEN TREATGUT BIOTECHNOLOGY CO LTD
  • US20260014212A1 patent drawing
  • US20260014212A1 patent drawing
  • US20260014212A1 patent drawing

AI summary

An intestinal microbiota product, a capsule, a preparation method and device therefore, and use thereof in precise microbiota transplantation are provided, relating to the technical field of intestinal microbiota transplantation. The composition provided by the present disclosure at least includes an eluent and a protective agent. The eluent includes a plant extract and Magnolia officinalis powder at a specific mass ratio, and the protective agent includes a small-molecular polyhydroxy compound, a macromolecular multipolymer, an amine substance, a natural emulsifier and an optional carbonate at a specific mass ratio. The two together constitute an organic whole.